60694-59-9

Usage

Explanation

The molecular formula represents the number of atoms of each element present in a molecule. In this case, the compound has 16 carbon (C) atoms, 19 hydrogen (H) atoms, 1 nitrogen (N) atom, and 2 oxygen (O) atoms.

Explanation

Spiro compounds are a class of organic compounds characterized by a fused ring system that contains two rings sharing a single atom. 1,4-Dioxaspiro[4.5]decane-8-carbonitrile, 8-(phenylmethyl)- belongs to this class.
3. Carbonitrile functional group

Explanation

The compound contains a carbonitrile functional group, which consists of a carbon atom triple-bonded to a nitrogen atom (C≡N).
4. Phenylmethyl substituent

Explanation

The compound has a phenylmethyl substituent, which is a benzene ring (C6H5) with a methyl group (CH3) attached.

Explanation

1,4-Dioxaspiro[4.5]decane-8-carbonitrile, 8-(phenylmethyl)is used in scientific research and may have potential applications in the development of pharmaceuticals or other biologically active compounds.

Explanation

The appearance of the compound (e.g., color, state of matter) is not mentioned in the provided material.

Explanation

The solubility of the compound in various solvents is not mentioned in the provided material.

Explanation

The stability of the compound under different conditions (e.g., temperature, pressure, pH) is not mentioned in the provided material.

Explanation

The reactivity of the compound with other substances or under specific conditions is not mentioned in the provided material.

Class

Spiro compounds

Applications

Scientific research and potential pharmaceutical development

Structure

Fused ring system

Appearance

Unknown (not provided in the material)

Solubility

Unknown (not provided in the material)

Stability

Unknown (not provided in the material)

Reactivity

Unknown (not provided in the material)

Upstream product

• 56868-63-4 4-benzyl-4-hydroxymethylcyclohexan-1-one ethylene ketal methanesulfonate 

Downstream Products

• 1202462-35-8 [1-(1-benzyl-4-oxo-cyclohexyl)-propyl]-carbamic acid tert-butyl ester 
• 1202462-37-0 [1-(1-benzyl-4-hydroxy-cyclohexyl)-propyl]-carbamic acid tert-butyl ester 
• 1202462-36-9 [1-(1-benzyl-4-hydroxy-cyclohexyl)-propyl]-carbamic acid tert-butyl ester 

Relevant academic research and scientific papers

6-SUBSTITUTED ISOQUINOLINES AND ISOQUINOLINONES

The invention relates to 6-substituted isoquinoline and isoquinolinone derivatives of the formula (I) useful for the treatment and/or prevention of diseases associated with Rho-kinase and/or Rho-kinase mediated phosphorylation of myosin light chain phosph

Benzospiran derivatives

This invention relates to novel benzospiran derivatives embraced by the formula SPC1 Wherein the sum of A and B is at least the integer 2; A is selected from the group consisting of --(CH2)n -- wherein n is 1 through 5 and --(Cn H2n --2 XY)-- wherein X is selected from the group consisting of hydroxy, acetoxy, amino and acetamido and Y is hydrogen, and X when taken together with Y is selected from the group consisting of =O and =CR3 R4 wherein R3 and R4 are selected from the group consisting of hydrogen and lower alkyl of 1 through 3 carbon atoms; B is absent or --(CH2)n -- wherein n is 1 through 3; R1 is selected from the group consisting of hydrogen and lower alkyl of 1 through 3 carbon atoms; R2 is selected from the group consisting of hydrogen, lower alkyl of 1 through 3 carbon atoms, EQU1 WHEREIN N IS 2 THROUGH 5 AND Ar is phenyl having zero through three substituents selected from the group consisting of lower alkyl of 1 through 3 carbon atoms, lower alkoxy of 1 through 3 carbon atoms, bromine, chlorine and fluorine; R1 and R2 taken together with --N is a saturated heterocyclic amino radical selected from the group consisting of unsubstituted and substituted pyrrolidino, piperidino, and hexamethylenimino; Z is selected from the group consisting of hydrogen, lower alkyl of 1 through 3 carbon atoms, lower alkoxy of 1 through 3 carbon atoms, nitro, amino, monoalkylamino of 1 through 3 carbon atoms, acylamido of 1 through 4 carbon atoms, bromine, chlorine and fluorine; and a pharmacologically acceptable acid addition salt thereof. It also relates to intermediates and processes for the preparation of the aforesaid novel compounds (1) and novel derivatives thereof. The administration to humans and animals of the novel compounds (1) depresses their central nervous systems and lowers their blood pressures.